'Sun Pharma Shares' - 93 News Result(s)

  • Aurobindo Gains on FDA Nod; Sun Pharma, Wockhardt Trade Mixed
    Aurobindo Gains on FDA Nod; Sun Pharma, Wockhardt Trade Mixed

    Aurobindo Pharma shares jumped as much as 3.3 per cent to hit intraday high of Rs 779.70 after the company got approval from the US Food and Drug Administration (USFDA) to manufacture and market generic version of Eli Lilly's Evista tablets used for treatment of osteoporosis in post-menopausal women.

  • JSPL Shares Rebound After Sinking 9%
    JSPL Shares Rebound After Sinking 9%

    Stocks that will become a part of the MSCI India index, or those whose weightage is slated to go up, are likely to witness buying from passive funds which track the MSCI India index. Stocks which will be excluded from the index are likely to witness selling from passive funds.

  • Sun Pharma Surges as Margins Beat Estimates in Q1
    Sun Pharma Surges as Margins Beat Estimates in Q1

    Sun Pharma's revenue growth was driven by the Indian formulation business, which posted an annual growth of 11 per cent to Rs 1,784 crore and emerging markets business, which grew 10 per cent year-on-year to Rs 845 crore.

  • Jefferies Maintains Buy Call on Sun Pharma Despite Adverse Guidance
    Jefferies Maintains Buy Call on Sun Pharma Despite Adverse Guidance

    International brokerage house Jefferies said it is positive about Sun Pharmaceutical Industries' strong key fundamentals, though its stock plunged 15 per cent on Tuesday, a day after the company warned of a deeper cut in bottom line and topline this year due to its ongoing integration with Ranbaxy.

  • Sensex Choppy; Infosys Supports, Sun Pharma Drags
    Sensex Choppy; Infosys Supports, Sun Pharma Drags

    Indian shares were little changed in choppy trading on Tuesday as investors remained focussed on corporate earnings, while Infosys issued an upbeat outlook and Sun Pharmaceutical Industries warned on 2016 sales.

  • Sun Pharma Slumps 16% on Sales Warning
    Sun Pharma Slumps 16% on Sales Warning

    Analysts estimate a roughly 8-10 per cent hit to profit for the year as Sun Pharma struggles to fix manufacturing problems at one of its own key plants and those of Ranbaxy Laboratories, the troubled rival it bought last year.

  • Sun Pharma Tanks 16% on Profit Warning
    Sun Pharma Tanks 16% on Profit Warning

    Shares of Sun Pharmaceutical Industries slumped as much as 16 per cent to Rs 799 on Tuesday after India's largest drugmaker issued an earnings warning.

  • Why Sun Pharma is Top Nifty Loser Today
    Why Sun Pharma is Top Nifty Loser Today

    Sun Pharmaceutical shares fell over 8 per cent on Monday following the drugmaker's disappointing quarterly results in the March quarter. Sun Pharma, India's largest drugmaker by sales, had posted its Q4 numbers post market hours on Friday.

  • Sun Pharma Falls After Ranbaxy Gets Slapped With Lawsuit
    Sun Pharma Falls After Ranbaxy Gets Slapped With Lawsuit

    Sun Pharma is India's largest drugmaker.

  • Sun Pharma Rebounds on Value Buying, Stock Jumps Nearly 3%
    Sun Pharma Rebounds on Value Buying, Stock Jumps Nearly 3%

    The shares of Sun Pharma slumped 10 per cent in trades on Tuesday after Japan's Daiichi Sankyo sold its 8.9 per cent stake in India's biggest drugmaker at a discount.

  • Dilip Shanghvi Did Not Buy Daiichi Sankyo's Shares: Sun Pharma
    Dilip Shanghvi Did Not Buy Daiichi Sankyo's Shares: Sun Pharma

    The company was clarifying on speculations that Mr Sanghvi, who holds 9.61 per cent stake in Sun Pharma, had bought shares when Daiichi Sankyo exited from the Indian firm.

  • Wipro, Yes Bank, Natco Pharma in Focus Today
    Wipro, Yes Bank, Natco Pharma in Focus Today

    The Nifty is likely to open lower on Wednesday tracking lacklustre cues from the global markets. Foreign investors bought shares worth Rs 17,489 crore on Tuesday, but this amount includes purchases of Sun Pharma shares sold by Japan's Daiichi Sankyo, which exited the company.

  • NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment
    NSE Sees Record High at Rs 41,165 Cr in Cash Market Segment

    Daiichi which had forayed into the Indian pharmaceutical market by buying a majority stake in Ranbaxy Laboratories in 2008 for Rs 22,000 crore, today sold over 21 crore shares in Sun Pharma.

  • Sensex, Nifty Flat; Sun Pharma, HCL Tech Shares Slump
    Sensex, Nifty Flat; Sun Pharma, HCL Tech Shares Slump

    Shares of Sun Pharmaceutical Industries slumped over 10 per cent to hit intraday low of Rs 938 after Daichi Sankyo planned to sell 8.9 per cent stake in Sun Pharma.

  • Sun Pharma Slumps Over 10% as Daiichi Exits
    Sun Pharma Slumps Over 10% as Daiichi Exits

    Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Sun Pharmaceutical Industries.

  • Pharma Stocks Fall on Bank of America Merrill Lynch Downgrade
    Pharma Stocks Fall on Bank of America Merrill Lynch Downgrade

    Shares of Sun Pharma fell nearly 4 per cent to hit low of Rs 1,116 after Bank of America Merill Lynch downgraded the stock to 'underperform' from 'buy'.

  • Sensex Edges Down in Cautious Trade; Sun Pharma Rises
    Sensex Edges Down in Cautious Trade; Sun Pharma Rises

    Shares have retreated since hitting record highs early this month, as analysts warned about waning momentum and low trading volumes ahead of the end of the fiscal year at the end of March.

  • Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments
    Sun Pharma Gets RBI Nod for Transfer of Ranbaxy Overseas Investments

    Sun Pharmaceutical Industries has received approval from the Reserve Bank of India (RBI) for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of the $4-billion merger deal between the companies.

  • Sun Pharma, Ranbaxy, JSPL in Focus Today
    Sun Pharma, Ranbaxy, JSPL in Focus Today

    The Nifty opened flat on Tuesday. However, sentiment is likely to be positive as both foreign and domestic investors turned net buyers of Indian equities on Monday. Foreign investors bought shares worth Rs 417 crore while, domestic investors were net buyers to the tune of Rs 404 crore in cash market. Trading volume declined on Monday; cash segment ...

  • Why SPARC Shares Surged Over 40% in March
    Why SPARC Shares Surged Over 40% in March

    The trading volumes in the month so far has been very high; on Monday as many as 6 million shares of SPARC changed hands on the BSE.

Advertisement

Advertisement

Market Data provided by © Accord Fintech.
© Copyright NDTV Convergence Limited 2015. All rights reserved.